Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 SEOM clinical guidelines for the treatment of small-cell lung cancer.

Literature DB >> 20080468

SEOM clinical guidelines for the treatment of small-cell lung cancer.

Angel Artal Cortés¹, Manuel Dómine Gómez, Albert Font Pous, Rosario García Campelo, Manuel Cobo Dolls, Dolores Isla Casado.

Abstract

Entities: Disease

Mesh：

Year: 2010 PMID： 20080468 DOI： 10.1007/s12094-010-0463-2

Source DB: PubMed Journal: Clin Transl Oncol ISSN： 1699-048X Impact factor: 3.405

× No keyword cloud information.

16 in total

1. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group.

Authors: A Aupérin; R Arriagada; J P Pignon; C Le Péchoux; A Gregor; R J Stephens; P E Kristjansen; B E Johnson; H Ueoka; H Wagner; J Aisner
Journal: N Engl J Med Date: 1999-08-12 Impact factor: 91.245

2. A meta-analysis of thoracic radiotherapy for small-cell lung cancer.

Authors: J P Pignon; R Arriagada; D C Ihde; D H Johnson; M C Perry; R L Souhami; O Brodin; R A Joss; M S Kies; B Lebeau
Journal: N Engl J Med Date: 1992-12-03 Impact factor: 91.245

3. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.

Authors: Stein Sundstrøm; Roy M Bremnes; Stein Kaasa; Ulf Aasebø; Reidulv Hatlevoll; Ragnar Dahle; Nils Boye; Mari Wang; Tor Vigander; Jan Vilsvik; Eva Skovlund; Einar Hannisdal; Steinar Aamdal
Journal: J Clin Oncol Date: 2002-12-15 Impact factor: 44.544

4. Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer.

Authors: John R Eckardt; Joachim von Pawel; Zsolt Papai; Antoaneta Tomova; Valentina Tzekova; Theresa E Crofts; Sarah Brannon; Paul Wissel; Graham Ross
Journal: J Clin Oncol Date: 2006-05-01 Impact factor: 44.544

5. Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Medical Research Council Lung Cancer Working Party.

Authors: D J Girling
Journal: Lancet Date: 1996-08-31 Impact factor: 79.321

6. Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study.

Authors: B Jeremic; Y Shibamoto; N Nikolic; B Milicic; S Milisavljevic; A Dagovic; J Aleksandrovic; G Radosavljevic-Asic
Journal: J Clin Oncol Date: 1999-07 Impact factor: 44.544

Review 7. A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis.

Authors: C Mascaux; M Paesmans; T Berghmans; F Branle; J J Lafitte; F Lemaitre; A P Meert; P Vermylen; J P Sculier
Journal: Lung Cancer Date: 2000-10 Impact factor: 5.705

8. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.

Authors: Ramaswamy Govindan; Nathan Page; Daniel Morgensztern; William Read; Ryan Tierney; Anna Vlahiotis; Edward L Spitznagel; Jay Piccirillo
Journal: J Clin Oncol Date: 2006-10-01 Impact factor: 44.544